Dear Colleagues,
Welcome to the inaugural issue of Catalyst, a new Lilly Oncology monthly eNews platform. In chemistry, a catalyst is a substance that increases the rate of a chemical reaction or change. At Lilly Oncology, our employees are our catalyst—your knowledge, passion, and expertise drive us forward, pushing us to deliver breakthrough treatments for the people and healthcare providers that need our medicines every day.

Catalyst is the first and only channel dedicated to Lilly Oncology. Its purpose is to align Lilly Oncology priorities with the day-to-day work of teams by highlighting business updates and industry news, celebrating successes, and fostering relationships across the network. As we progress through the year, employees from all areas will be engaged to contribute. It is our dedicated platform and its success will come from our collective commitment to ongoing and transparent communication.

I encourage all of you to read this and future issues of Catalyst and to view it as a platform to recognize the innovative and meaningful work that makes Lilly Oncology unique.

Sue Mahony


Sue Mahony: Spotlight on New LO Strategy


Levi Garraway: Prioritization of the Pipeline



We checked in with three of our LO colleagues to find out what they are most looking forward to at ASCO. Find out what they had to say.

What to Expect

As part of our new strategy, LO is aiming to shift to a new set of behaviors and actions to change the standard-of-care for patients.


There’s a lot going on in the world of Lilly Oncology, stay up to date with all the latest Company events and announcements.

Contact Us with questions or suggestions. 
Lilly Under the Scope is for internal use only by employees of Eli Lilly and Company and should not be distributed outside the company.